LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma today announced a European re-launch of Sculptra ® (injectable poly-L-lactic acid) - a collagen stimulator - with an updated administration protocol.

New data presented at this year’s American Society for Dermatologic Surgery Annual Meeting and published in the prestigious Journal of Drugs in Dermatology showcase Sculptra’s unique regenerative ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a new label for Galderma’s facial injectable Sculptra that adds new options for clinicians, ...

Galderma today announced a European re-launch of Sculptra (injectable poly-L-lactic acid) a collagen stimulator with an updated administration protocol. This means that the product is ready for use ...